BR112021024853A2 - Método implementado por computador para o desenvolvimento colaborativo de reagentes para a detecção de ácidos nucleicos-alvo - Google Patents

Método implementado por computador para o desenvolvimento colaborativo de reagentes para a detecção de ácidos nucleicos-alvo

Info

Publication number
BR112021024853A2
BR112021024853A2 BR112021024853A BR112021024853A BR112021024853A2 BR 112021024853 A2 BR112021024853 A2 BR 112021024853A2 BR 112021024853 A BR112021024853 A BR 112021024853A BR 112021024853 A BR112021024853 A BR 112021024853A BR 112021024853 A2 BR112021024853 A2 BR 112021024853A2
Authority
BR
Brazil
Prior art keywords
collaborative development
computer
detection
target nucleic
implemented method
Prior art date
Application number
BR112021024853A
Other languages
English (en)
Inventor
Hoon Lee Dae
Yoon Chun Jong
Chul Choi Youn
Wook Kim Young
Jee Kim Yun
Original Assignee
Seegene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seegene Inc filed Critical Seegene Inc
Publication of BR112021024853A2 publication Critical patent/BR112021024853A2/pt

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/80—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for detecting, monitoring or modelling epidemics or pandemics, e.g. flu
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00—Administration; Management
    • G06Q10/10—Office automation; Time management
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00—Administration; Management
    • G06Q10/10—Office automation; Time management
    • G06Q10/101—Collaborative creation, e.g. joint development of products or services
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00—Administration; Management
    • G06Q10/10—Office automation; Time management
    • G06Q10/103—Workflow collaboration or project management
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Business, Economics & Management (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • Human Resources & Organizations (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Entrepreneurship & Innovation (AREA)
  • Strategic Management (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • Evolutionary Biology (AREA)
  • Public Health (AREA)
  • Data Mining & Analysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Primary Health Care (AREA)
  • Quality & Reliability (AREA)
  • General Business, Economics & Management (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Library & Information Science (AREA)
  • Economics (AREA)
  • Marketing (AREA)
  • Operations Research (AREA)
  • Bioethics (AREA)
  • Tourism & Hospitality (AREA)
  • Medicinal Chemistry (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Evolutionary Computation (AREA)
  • Software Systems (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)

Abstract

método implementado por computador para o desenvolvimento colaborativo de reagentes para a detecção de ácidos nucleicos-alvo. a divulgação se refere a um método implementado por computador, um sistema e um meio de armazenamento para o desenvolvimento colaborativo de um reagente para a detecção do ácido nucleico-alvo. de acordo com a divulgação, o método, o sistema e o meio de armazenamento se correlacionam automaticamente com o desenvolvedor e o fornecedor de tecnologia, adequados para as características de desenvolvimento colaborativo, em resposta a uma solicitação do desenvolvimento colaborativo, aumentando, assim, a eficiência do desenvolvimento colaborativo.
BR112021024853A 2019-06-14 2020-06-12 Método implementado por computador para o desenvolvimento colaborativo de reagentes para a detecção de ácidos nucleicos-alvo BR112021024853A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20190070900 2019-06-14
KR20190177063 2019-12-27
PCT/KR2020/007664 WO2020251306A1 (en) 2019-06-14 2020-06-12 Computer-implemented method for collaborative development of reagents for detection of target nucleic acids

Publications (1)

Publication Number Publication Date
BR112021024853A2 true BR112021024853A2 (pt) 2022-01-18

Family

ID=73782169

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021024853A BR112021024853A2 (pt) 2019-06-14 2020-06-12 Método implementado por computador para o desenvolvimento colaborativo de reagentes para a detecção de ácidos nucleicos-alvo

Country Status (9)

Country Link
US (1) US20220180971A1 (pt)
EP (1) EP3924975A4 (pt)
JP (1) JP7353396B2 (pt)
KR (1) KR20210153154A (pt)
CN (1) CN113966535A (pt)
AU (2) AU2020291343A1 (pt)
BR (1) BR112021024853A2 (pt)
CA (1) CA3138015A1 (pt)
WO (1) WO2020251306A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023243922A1 (ko) * 2022-06-15 2023-12-21 주식회사 씨젠 기술 문서를 생성하는 방법 및 장치
CN115166153B (zh) * 2022-07-20 2024-10-15 广州蓝勃生物科技有限公司 试剂开发的实验方法、装置、计算机设备和存储介质
CN115166154B (zh) * 2022-07-20 2024-10-18 广州蓝勃生物科技有限公司 试剂开发实验方法、装置、计算机设备和存储介质
WO2024085731A1 (ko) * 2022-10-20 2024-04-25 주식회사 씨젠 타겟 핵산 분자 검출용 시약 개발에 필요한 복수 개의 세부 성능 실험 가이딩 및 실험 결과 기록서 정리 방법
WO2024090987A1 (ko) * 2022-10-25 2024-05-02 주식회사 씨젠 분자 진단용 어플리케이션을 관리하는 방법 및 장치
WO2024123122A1 (ko) * 2022-12-08 2024-06-13 주식회사 씨젠 체외 진단용 시약 제품의 연구개발 관리 장치 및 방법
WO2024123131A1 (ko) * 2022-12-08 2024-06-13 주식회사 씨젠 체외 진단용 시약 제품의 연구개발 모듈을 업데이트하는 방법 및 연구 개발 관리 장치

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Methods and kits for amplification and testing of nucleic acid sequences
JP2846018B2 (ja) 1988-01-21 1999-01-13 ジェネンテク，インコーポレイテッド 核酸配列の増幅および検出
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
GB9812768D0 (en) 1998-06-13 1998-08-12 Zeneca Ltd Methods
JP2002169942A (ja) 2000-12-04 2002-06-14 Hiroshi Maeda 新技術開発システム
JP2005516300A (ja) * 2002-01-25 2005-06-02 アプレラ コーポレイション 製品およびサービスに対する注文を発注し、受理し、および充足する方法
JP2005215923A (ja) 2004-01-29 2005-08-11 Fukuda Denshi Co Ltd 情報提供サーバ及び臨床データ収集システム
US20070021919A1 (en) * 2005-07-19 2007-01-25 Leproust Eric M Silico design of chemical arrays
WO2007030571A2 (en) * 2005-09-06 2007-03-15 Molecular Image Inc. Identification of targets and development of reagents for testing and molecular imaging of human disease
CN102187215A (zh) 2008-09-09 2011-09-14 生物辐射实验室股份有限公司 基于回归的多级pcr分析系统
JP2011150387A (ja) 2010-01-19 2011-08-04 Nomura Research Institute Ltd 実験データ管理装置
US8655945B2 (en) * 2010-11-16 2014-02-18 International Business Machines Corporation Centralized rendering of collaborative content
JP2013127762A (ja) 2011-12-19 2013-06-27 Rumi Miyato 再生医療技術の収集・実施の管理システム
WO2015147370A1 (en) 2014-03-28 2015-10-01 Seegene, Inc. Detection of target nucleic acid sequences using different detection temperatures
WO2016052991A1 (en) 2014-10-01 2016-04-07 Seegene, Inc. Methods for analyzing samples
KR102016747B1 (ko) 2014-12-09 2019-09-02 주식회사 씨젠 상이한 검출 온도 및 기준값을 사용한 타겟 핵산 서열의 검출
WO2017086762A1 (en) 2015-11-20 2017-05-26 Seegene, Inc. Method for calibrating a data set of a target analyte
KR20170113192A (ko) * 2016-03-24 2017-10-12 경희대학교 산학협력단 협업 가상 데스크톱 서비스 시스템 및 그 방법
KR101827978B1 (ko) * 2016-06-17 2018-02-09 (주)잼투고 퍼포머 객체 기반의 협연 서비스 제공서버 및 제공방법
JP7012151B2 (ja) 2017-09-28 2022-01-27 シージーン アイエヌシー 試料内ターゲット分析物を分析する方法及び装置

Also Published As

Publication number Publication date
EP3924975A4 (en) 2022-11-23
KR20210153154A (ko) 2021-12-16
EP3924975A1 (en) 2021-12-22
WO2020251306A1 (en) 2020-12-17
AU2023263429A1 (en) 2023-11-23
CA3138015A1 (en) 2020-12-17
JP2022536342A (ja) 2022-08-15
CN113966535A (zh) 2022-01-21
US20220180971A1 (en) 2022-06-09
AU2020291343A1 (en) 2021-12-02
JP7353396B2 (ja) 2023-09-29

Similar Documents

Publication Publication Date Title
BR112021024853A2 (pt) Método implementado por computador para o desenvolvimento colaborativo de reagentes para a detecção de ácidos nucleicos-alvo
Gupta et al. Point-of-care PCR assays for COVID-19 detection
Nierhaus Mg2+, K+, and the ribosome
Foo et al. Improving microbial biogasoline production in Escherichia coli using tolerance engineering
BR112021020608A8 (pt) Rna recrutador de desaminase, construção, método para editar um rna alvo em uma célula hospedeira, e, construção, composição, célula, biblioteca ou kit
Yang et al. Prediction and characterization of promoters and ribosomal binding sites of Zymomonas mobilis in system biology era
BR112014025384A8 (pt) método e sistema para executar ensaio automatizado e métodos para executar teste reflexivo em vários exemplares
BR112022002695A2 (pt) Nucleases guiadas por rna, fragmentos ativos e variantes das mesmas e métodos de uso
BR112012017267A2 (pt) ácidos graxos de cadeia ramificada dispersos e produção biológica dos mesmos
Frederix et al. Development of a native Escherichia coli induction system for ionic liquid tolerance
AR079704A1 (es) Anticuerpos anti-bv8 y sus usos
Wang et al. The temperature dependent proteomic analysis of Thermotoga maritima
Sunner et al. Glucuronoyl esterase screening and characterization assays utilizing commercially available benzyl glucuronic acid ester
BR102012019429A8 (pt) Método para determinar um valor de saída elétrica de um conversor de energia renovável, método para controle de um valor da saída elétrica, sistema de geração de energia elétrica, meios de um processamento programado e operavél para executar instruções, inversor, meio de registro com instruções armazenadas para execução por meios de processamento, programa de computador, sistema que compreende uma memória e um processador e meio legível por computador
Dai et al. Lipopolysaccharide stimulates the growth of bacteria that contribute to ruminal acidosis
Petrezsélyová et al. Regulation of the Na+/K+-ATPase Ena1 expression by calcineurin/Crz1 under high pH stress: a quantitative study
BR112015016495A8 (pt) Composições, complexo de ácidos nucleicos e célula e meio não transitório legível por computador
Bóna et al. Tissue tropism of H9N2 low-pathogenic avian influenza virus in broiler chickens by immunohistochemistry
BR112014014095A2 (pt) método, sistema, e meio de armazenamento legível por computador não transitório
DE602006014505D1 (de) Verfahren zum nachweis lebensfähiger zellen in ein
BR112022000481A2 (pt) Conjuntos de anticorpos e de ácidos nucleicos, vetor de expressão, célula hospedeira e métodos de pré-direcionamento de radioimunoterapia e de direcionamento de um radioisótopo
Marentette et al. Impaired Expression of prostaglandin E2 (PGE2) synthesis and degradation enzymes during differentiation of immortalized urothelial cells from patients with interstitial cystitis/painful bladder syndrome
Yehia et al. Reverse transcription recombinase polymerase amplification assay for rapid detection of avian influenza virus H9N2 HA gene
Show et al. Microalgae for Environmental Biotechnology: Smart Manufacturing and Industry 4.0 Applications
ES2542621B1 (es) Polipéptidos con actividad polisacárido monooxigenasa y su uso para la producción de azúcares fermentables